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Abstract
Background: Excessive exposure to light enhances the progression and severity of some human retinal degenerative
diseases. While retinal microglia are likely to be important in neuron damage associated with these diseases, the
relationship between photoreceptor damage and microglial activation remains poorly understood. Some recent studies
have indicated that the chemokine fractalkine is involved in the pathogenesis of many neurodegenerative diseases. The
present study was performed to investigate the cross-talk between injured photoreceptors and activated retinal microglia,
focusing on the role of fractalkine and its receptor CX3CR1 in light-induced photoreceptor degeneration.
Methodology/Principal Findings: Both in vivo and in vitro experiments were involved in the research. In vivo, Sprague–
Dawley rats were exposed to blue light for 24 hours. In vitro, the co-culture of primary retinal microglia and a photoreceptor
cell line (661W cell) was exposed to blue light for five hours. Some cultures were pretreated by the addition of anti-CX3CR1
neutralizing antibody or recombinant fractalkine. Expression of fractalkine/CX3CR1 and inflammatory cytokines was
detected by immunofluorescence, real-time PCR, Western immunoblot analysis, and ELISA assay. TUNEL method was used
to detect cell apoptosis. In addition, chemotaxis assay was performed to evaluate the impact of soluble fractalkine on
microglial migration. Our results showed that the expression of fractalkine that was significantly upregulated after exposure
to light, located mainly at the photoreceptors. The extent of photoreceptor degeneration and microglial migration
paralleled the increased level of fractalkine/CX3CR1. Compared with the control, the expression of inflammatory cytokines
was significantly downregulated in the anti-CX3CR1 neutralizing antibody-treated group, and the number of
photoreceptors was also well preserved. The addition of recombinant full-length fractalkine or soluble fractalkine resulted
in fewer TUNEL-positive photoreceptors and an increased number of migratory microglia respectively.
Conclusions/Significance: These findings demonstrate that fractalkine/CX3CR1 interaction may play an important role in
the photoreceptor-microglia cross-talk in light-induced photoreceptor degeneration.
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Introduction
Excessive exposure to light enhances the progression and
severity of some human retinal degenerative diseases, such as age-
related macular degeneration, and some forms of retinitis
pigmentosa due to irreversible photoreceptor apoptosis [1].
Understanding the process of photoreceptor apoptosis might
provide evidence for how to interfere with photoreceptor loss and
therefore loss of vision in these diseases.
Microglia located in the inner retina are defined as the resident
macrophages of the central nervous system (CNS) [2]. Some
evidence indicates that microglial activation contributes to neuron
damage in neurodegenerative diseases [3–5]. In response to
certain environmental changes, microglia can become over-
activated and therefore exert detrimental neurotoxic effects by
the excess production of cytotoxic factors [6–8]. Our previous
finding suggests that inhibition of microglial activation by
naloxone is neuroprotective in a model of light-induced photore-
ceptor degeneration [9]. Although the involvement of microglia is
certain, the relationship between photoreceptor damage and
microglial activation remains poorly understood [10].
Recently, an increasing number of studies have focused on the
signal cross-talk between neurons and microglia [11]. Chemokines
are a family of relatively low molecular mass proteins that chemo-
attract and activate inflammatory cells [12]. Different from most
other chemokines, fractalkine is a peculiar chemokine belonging to
the CX3C subfamily that exists as both soluble and membrane-
bound forms [13]. It is constitutively expressed by neurons
throughout the CNS, whereas its sole receptor, CX3CR1, is
restricted to major microglia in the CNS [14–16]. Under
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can be cleaved into the soluble form by the activation of
metalloproteases [17–18]. This pattern of expression makes the
ligand–receptor pair fractalkine/CX3CR1 appear to be an ideal
candidate to mediate neural/microglial interaction [19].
Recent studies show that fractalkine is involved in the
pathogenesis of many clinical diseases including pancreatitis
[20], rheumatoid arthritis [21], AIDS [22], atherosclerosis
[23,24], age-related macular degeneration [25–27], neuropathic
pain [28–30], and cancer [31–33]. It is also suggested that the
fractalkine/CX3CR1 in the CNS not only modulates the
recruitment/activation of immune cells [34,35], but might also
exert multiple effects on neurons [36–38]. Indeed, the role of
fractalkine/CX3CR1 is still quite controversial. For example,
CX3CR1-deficient mice showed reduced inflammation and injury
in models of cerebral ischemia [39–41], Alzheimer’s disease (AD)
[42], and mutant tau/APP-associated neurodegeneration [43]. On
the other hand, loss of CX3CR1 exaggerates neuron apoptosis in
Parkinson’s disease [27], amyotrophic lateral sclerosis [27], and
encephalomyelitis [44]. This indicates that fractalkine/CX3CR1
might play different and even opposite roles in different disease
models [36].
In contrast to a tremendous amount of research on the brain,
little is known about the role of fractalkine/CX3CR1 in light-
induced photoreceptor degeneration. We hypothesized that
photoreceptor damage due to excessive light exposure would
result in membrane-bound form fractalkine cleavage into soluble
form and then enhanced microglial activation, which would be
driven by the further loss of photoreceptors throughout the
degenerative process.
Therefore, the purpose of this study was to determine the role of
fractalkine/CX3CR1 interaction in light-induced photoreceptor
apoptosis. In this work, we investigated the changes in fractalkine/
CX3CR1 expression after light damage, as well as the regulation
of microglial functions mediated by the fractalkine/CX3CR1
ligand/receptor pair, in both the in vivo type I retinal photic injury
model and the in vitro photoreceptor/microglia co-culture system.
Our data show that the alteration in the forms of fractalkine
protein expressed due to light damage exacerbates retinal
inflammation and photoreceptor apoptosis by increased recruit-
ment of activated microglia and excess production of inflamma-
tory cytokines. In addition, the blockade of soluble-form fractalk-
ine activity by means of a neutralizing monoclonal antibody partly
delayed the degenerative process of photoreceptors and, in
contrast, exogenous membrane-bound form fractalkine adminis-
tration promoted photoreceptor survival, suggesting that the
equilibrium between membrane-bound and soluble-form fractalk-
ine plays an important role in the biological activity of fractalkine/
CX3CR1. Taken together, these findings suggest that fractalkine/
CX3CR1 represents a potential novel therapeutic target to




All procedures were conducted in accordance with the ARVO
statement for the Use of Animals in Ophthalmic and Vision
Research, and the study was approved by the Animal Ethics
Committee of the Eye and ENT Hospital of Fudan University.
Adult male Sprague–Dawley rats, each weighing 200 to 230 g,
were maintained in a 12-hour light/12-hour dark cycle. They
were fed ad libitum and had free access to water.
Cell Culture
Primary retinal microglia culture. Retinas were isolated
from newborn Sprague-Dawley rats by mechanical dissociation
and then incubated in 0.25% trypsin, 1 mM EDTA (Invitrogen,
Carlsbad, CA) to generate single cell suspension. The enzyme-
treated tissues were then triturated with a pipette and the trypsin
was inactivated by fetal bovine serum (FBS) (Gibco, Carlsbad,
CA). Cells were collected by centrifugation and re-suspended in
DMEM/F-12 medium (Gibco, Carlsbad, CA) containing 10%
FBS and 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis,
MO). The cells were seeded in 75 cm
2 culture flasks and incubated
at 37uC in a humidified 5% CO2 atmosphere. After two or three
weeks of growth, mixed glial cells were shaken at 250 rpm for
4 hours and the supernatant containing an enriched microglia
were harvested to reseed.
661W cell culture. The 661W photoreceptor cell line was
kindly provided by Dr. Muayyad Al-Ubaidi (University of
Oklahoma Health Sciences Center, Oklahoma City, OK) [45]
and maintained in DMEM/High glucose medium (Gibco,
Carlsbad, CA) containing 10% FBS and 1% penicillin/
streptomycin at 37uC in a humidified 5% CO2 atmosphere.
Co-culture of retinal microglial cells with 661W
cells. Freshly collected microglia were reseeded onto 6 well
transwell collagen-coated membrane inserts (Corning, Corning,
NY). Separately, 661W cells were grown to confluence in a 6 well
plate. After 24 hours incubation intheir basal medium respectively,
the previously prepared transwell inserts containing retinal
microglia were then placed into wells with 661W cells. Before light
exposure, some inserts of microglia were pretreated by the addition
of anti-CX3CR1 neutralizing antibody (Torrey Pines Biolab, La
Jolla, CA) or recombinant full-length fractalkine (R&D Systems,
Minneapolis, MN) for 5 hours. Then microglia-661W cell co-
cultures and controls undergone the light exposure. The 0.4 um
pore size of the transwell prevents direct cell–cell interactions but
allowsthediffusionofsolublefactorsthroughthemembrane(Fig.1).
Light exposure of the SD rats. SD rats were anesthetized by
intraperitoneal injection of ketamine (50 mg/kg) and xylazine
(10 mg/kg). Pupils were fully dilated with 1% atropine. The rats
were placed separately in cages. After 24 hours’ dark adaptation,
they were exposed to blue light at an intensity of 2500 lux for
24 hours. After that, they were placed in darkness for another
24 hours and then were returned to the normal light/dark cycle.
Light exposure of the 661W cells. The 661W cells were
seeded in a 6 or 12 well culture plate (Corning, Corning, NY) for
24 hours followed by 5 hours of intense blue light exposure set at
6000 lux in a light box which was equipped with 16 blue LED
lamps fixed on the superior and inferior side. The temperature was
maintained at 37uC and the control cells were shielded from light
and were kept under conditions similar to those for the cells in the
light exposure.
Figure 1. Illustration of the transwell co-culture system and the
chemotaxis assay. The transwell consists of two chambers separated
by a porous membrane. The 661W cells were placed on the bottom of
the lower chamber while the microglial cells were placed on the
membrane of the upper chamber.
doi:10.1371/journal.pone.0035446.g001
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Anesthetized rats were transcardially perfused with 0.9% saline,
followed by 4% paraformaldehyde (PFA) solution in 0.1 M
phosphate buffer. The eyes were enucleated and postfixed in 4%
PFA for 2 hours, then transferred to formalin overnight. The eyes
were paraffin embedded and sectioned at 5-um thickness.
Histopathological evaluation was performed on sections of the
ones through optic nerves using hematoxylin and eosin (HE)
staining. Three defined regions were selected in the superior
hemisphere for measurements: two were located at points 450 mm
away from the ora serrata and the optic nerve head, while the
third was chosen at the midpoint. Five 100-mm consecutive
sections were measured for each region. The thickness of the outer
nuclear layer (ONL) was determined by an image-analysis system.
For immunohistochemical studies of retinal sections, after
postfixation, the eyecups without anterior segments were trans-
ferred to 20%–30% graded sucrose solutions overnight at 4uC and
then embedded in OCT compound. Frozen sections were cut at
10 mm thick with a cryostat and the sections were kept in a 220uC
freezer until use. The retinal sections or cells were fixed with 4%
PFA for 30 min. After being washed with PBS, they were
permeabilized with 0.5% Triton for 15 min followed by blocking
with 10% goat serum in PBS for 1 hour at room temperature.
Subsequently, they were incubated with primary antibodies
overnight at 4uC. The following antibodies were used: fractalkine
and CX3CR1 antibody (1:150, Torrey Pines Biolab, La Jolla, CA),
OX-42 antibody (1:200, Abcam, MA, USA), recoverin antibody
(1:200, Santa Cruz Biotechnology, Santa Cruz, CA). After rinsing
with PBS, the sections or cells were incubated with appropriate
secondary antibodies (Invitrogen, Carlsbad, CA) for 1 hour.
Finally they were counterstained with DAPI (Sigma-Aldrich, St.
Louis, MO) and examined by laser confocal microscope (Leica
Microsystems).
TUNEL staining
TUNEL was performed using a fluorescent DNA fragmentation
detection kit (Roche, Nutley, NJ) according to the manufacturer’s
instructions. The field was chosen randomly, and nine fields were
chosen for every specimen. The number of TUNEL-positive cells
was counted to obtain the ratio of TUNEL positivity to the total
number of cells.
Western Blot Analysis
SD rats were sacrificed 2 hours, 6 hours, 1, 3, 5 or 7 days after
the light damage. Six retinas were used for each time point. The
retinas were homogenized using ultrasound. Equal amounts of
proteins were then loaded and separated on SDS-PAGE and were
transferred to PVDF membranes (Millipore, Billerica, MA). The
membranes were blocked in 5% nonfat milk TBST (20 mM Tris,
150 mM NaCl, 0.1% Tween, pH 7.4) for 30 min and sub-
sequently incubated in primary antibodies overnight at 4uC. After
washing, the secondary antibodies were added, and then the
labeled proteins were revealed. Quantitative measurement of band
intensity was made and normalized against internal controls
Real-time PCR
The total RNA was extracted using trizol RNA extraction
reagent (Invitrogen, Carlsbad, CA), according to the manufac-
turer’s instructions. One microgram of total RNA was reverse-
transcribed into cDNA. Real-time PCR was performed using the
ABI Prism 7900 Sequence Detection system (Applied Biosystems).
The primers for amplifications of fractalkine, CX3CR1, TNF-
a,IL-1b were synthesized by Shenggong (Shanghai) company. The
reactions were set up with 10 ul SYBR Green PCR Master Mix
(Takara, Shuzo, Kyoto, Japan), 1.0 ul 10 umol primer mixture,
and 2 ul cDNA template. The real-time PCR was performed
following the conditions: 95uC for 10 seconds followed by 35
cycles of indicated temperature and 72uC for 30 seconds. Relative
mRNA levels of target genes were normalized to beta-actin.
Figure 2. Hematoxylin–eosin and TUNEL staining of SD rat
retinas showed progressive changes in the ONL thickness and
photoreceptor apoptosis in the in vivo light-induced photore-
ceptor degeneration model. (A–E) Compared with the normal
group, the photoreceptor number and ONL thickness decreased
markedly at different time points after exposure to light (black arrow).
(F–I) A few hours after exposure to light, TUNEL-positive cells began to
appear in the ONL. (J–K) At 1 day, the number of TUNEL-positive cells
reached a peak in the ONL. (L–O) TUNEL-positive cells gradually
decreased at 3 and 5 days. (P–Q) At 7 days, TUNEL fluorescence was
almost completely absent.
doi:10.1371/journal.pone.0035446.g002
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After light exposure was performed on the cell cultures, the
supernatants were collected at 6, 12, 24, 36, 48 hours for enzyme-
linked immunosorbent assay (ELISA) measurement. The levels of
soluble fractalkine, TNF-a,IL-1b and IL-10 were evaluated with
the sandwich ELISA Kit according to manufacturer’s instructions
(R&D Systems, Minneapolis, MN). Working concentrations of
capture and detection antibodies were optimized to increase assay
sensitivity. Colorimetric analysis was performed using an Elisa
reader. Absorbance was obtained by subtracting readings at
540 nm from readings at 450 nm.
Chemotaxis assay
The microglial chemotaxis assay was performed with a chemo-
taxis apparatus that consists of two 12-well chambers separated by
a membrane containing 8-mm pores (BD Biosciences, San Jose,
CA) (Fig. 1). This assay is based on the premise of providing
a gradient of the chemotactic agent and allowing the cells to
migrate through a porous membrane toward the chemotactic
agent. Briefly, microglia were placed on the membrane of the
upper chamber (2.5610
5cells/well) while 661W cells were placed
on the bottom of the lower chamber (3610
5 cells/well). Cells were
allowed to adhere to the membranes or plates for 24 hours. To
assess the impact of soluble fractalkine on chemotaxis, microglia
were pretreated with anti-CX3CR1 antibody for 2 hours in some
wells, whereas recombinant soluble fractalkine was added in the
lower chamber of some other wells, prior to light exposure. After
Figure 3. The effect of intense blue light on 661W photoreceptor cell morphology and apoptosis. (A) In the normal control, 661W had
a flattened appearance with few intercellular spaces. (B) After light exposure, the cells became spindled with large intercellular spaces. (C–E) 661W
photoreceptors underwent apoptosis, as determined by TUNEL assay. (F) Statistical analysis showed that the TUNEL positivity was significantly
increased at 0 hour, 24 hours and 48 hours after light exposure.
doi:10.1371/journal.pone.0035446.g003
Figure 4. Immunolabeling with the OX42 antibody showed the
activation and migration of retinal microglia. (A) In normal
retinas, labeled microglia existed only in the GCL and IPL. (B) At 3 days
after exposure to light, plenty of microglia migrated to the outer retina.
(C–D) The microglial morphology changed from the resting ramified
state with long processes to the activated amoeboid appearance at 3
days after photic injury.
doi:10.1371/journal.pone.0035446.g004
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through the pores for an additional 1, 7, or 19 hours (6, 12,
24 hours from the beginning of light exposure). Microglial cells are
adherent cells which are more likely to attach to the underside of
the membrane, so the cells that did not migrate and remained on
the upper surface of the membrane were removed with a cotton
swab, and the ones that had migrated to the underside of the
membrane were stained with DAPI and counted. In at least three
independent experiments, three wells per treatment were counted
in nine random fields at 506magnification per well. The number
of microglial cells that migrated in response to injured 661W cells
was compared to the number of cells that migrated randomly in
the control group.
Statistical Analysis
All results are presented as mean6standard error. Data were
analyzed with Student’s t tests for comparisons between two
groups and with ANOVA for multiple comparisons (GraphPad




After 24 hours of blue light exposure, SD rats showed
progressive photoreceptor cell loss and a decrease in the ONL
thickness, with disorganization of the inner and outer segments of
the photoreceptors (Fig. 2A–E). At 7 days after light exposure, the
photoreceptors in the posterior retina were almost completely lost,
Figure 5. Immunofluorescence analysis of fractalkine in the retina at different time points after exposure to light. (A) In the normal
retina, fractalkine immunoreactivity showed a weak but widely distributed fluorescence. (B–F) At 6 hours, 1, 3, 5, 7 days after light exposure,
fractalkine staining increased in the photoreceptors.
doi:10.1371/journal.pone.0035446.g005
Figure 6. Double immunofluorescence analysis of CX3CR1 and
fractalkine at the 3-day time point after light exposure. (A–C)
Double staining for OX42 and CX3CR1 revealed that CX3CR1-positive
cells were reactive for the microglial marker. (D–I) Photoreceptors were
labeled by recoverin antibody and microglial cells were labeled by OX42
antibody. The two merged images showed that photoreceptors were
the source of increased fractalkine as well as the direction of microglial
migration.
doi:10.1371/journal.pone.0035446.g006
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thickness was significantly decreased compared with that of
normal rats (Fig. 2E). Detection of cell apoptosis during the
light-damage process was performed by TUNEL assay. Positive
cells were seen in the ONL as early as 2 hours after light exposure
and peaked at 1 day (Fig. 2F–K), and then the number of
TUNEL-positive cells gradually decreased due to photoreceptor
loss (Fig. 2L–Q). In the in vitro experiment, the appearance of
661W cells changed from flat with small intercellular spaces to
spindled with large intercellular spaces after exposure to blue light
for 5 hours (Fig. 3A–B), and 70% to 80% of them succumbed to
apoptosis (Fig. 3C–F).
Retinal microglial activation and migration in photic
injury
In normal retina, OX42-labeled microglial cells were found
only in the inner part of the retina, such as in the ganglion cell
layer (GCL), the inner plexiform layer (IPL), and the inner nuclear
layer (INL) (Fig. 4A). After 24 hours of light exposure, an
increasing number of microglia began to migrate into the ONL
and the subretinal space (Fig. 4B), appearing to change their
morphology from cells with long dendrites to amoeboid cells with
retracted processes as they became activated in retinal whole
mounts [46] (Fig. 4C–D).
Expression of fractalkine and CX3CR1 in the retina
The complementary expression of fractalkine on neurons and
CX3CR1 on microglia establishes a unique communication
whereby neurons constitutively express and release fractalkine to
regulate the function of microglia in various models of central
neurodegenerative diseases. This evidence led us to hypothesize
that the fractalkine–CX3CR1 axis participates in retinal de-
generation. We first confirmed the cellular source of fractalkine
and its receptor CX3CR1 in the retina. The level of fractalkine
immunoreactivity was low (Fig. 5A), but still clearly detectable
throughout the normal control retina, and double-labeled
immunofluorescence indicated that CX3CR1-positive cells were
exclusively microglia, due to their co-expression of the microglial
marker OX-42 (Fig. 6A–C). Next, to investigate whether
fractalkine and its receptor CX3CR1 were involved in retinal
photic injury, their mRNA and protein expression were examined
in the retina at 2 hours, 6 hours, 1, 3, 5, and 7 days after light
exposure. The results indicated that CX3CR1 expression was up-
regulated (P,0.05) (Fig. 7A, C, E). Similarly, compared with the
weak level of expression observed in the normal retina, fractalkine
Figure 7. Western blot and real-time PCR analyses for fractalkine/CX3CR1 expression in the retinas after exposure to light. (A–C) The
protein expressions of fractalkine and CX3CR1 began to increase at two hours after exposure to light and peaked at 1 day and 3 days respectively,
then decreased. (D–E) The mRNA results were normalized relative to levels in the normal control retinas.
doi:10.1371/journal.pone.0035446.g007
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ONL, was also significantly up-regulated after light damage
(Fig. 5B–F, 7A, B, D). At 6 hours and 1 day, its expression began
to upregulate at the segment layer first, whereas it appeared
mainly at the ONL layer at 3, 5, and 7 days. In photoreceptor–
microglia transwell co-cultures, light-damaged 661W photorecep-
tors resulted in microglial activation and subsequent further
degeneration of the remaining photoreceptors (Fig. 8A–H). We
then analyzed whether soluble fractalkine was released from light-
damaged 661W photoreceptors by evaluating its levels in the cell
supernatants. Results from the ELISA assay indicated that the
soluble fractalkine was not detected in the single microglial culture
group. However, in the co-culture group and the 661W control
group, soluble fractalkine was released over time after photic
injury, reaching a maximum concentration of about 2.8 ng/ml at
24 hours in the co-culture group (Fig. 9). From this we can
conclude that 661W cells were the cellular sources of soluble
fractalkine. This evidence also suggested that there is a close spatial
and temporal relationship among photoreceptor apoptosis,
fractalkine/CX3CR1 impairment, and microglial activation/
migration (Fig. 6D–I), indicating that the fractalkine/CX3CR1
ligand-receptor pair might be crucial for photoreceptor-microglial
cross-talk.
Up-regulated IL-1b and TNF-a expression after photic
injury
Activated microglia are known to produce pro-inflammatory
cytokines such as IL-1b and TNF-a that result in local
inflammatory responses and neurodegeneration [47,48]. There-
fore, we examined the levels of IL-1b and TNF-a at different time
points after exposure to light. Compared with the low levels in the
control retinas, the expressions of both IL-1b and TNF-a were up-
regulated in a time-dependent manner (Fig. 10A–E). ELISA
analysis also revealed that the levels of these factors were increased
in the co-culture cell supernatants (Fig. 10F–G).
Inhibition of light-induced IL-1b and TNF-a release by the
anti-CX3CR1 antibody
The increased release of soluble fractalkine after light exposure
prompted us to investigate whether it plays an active role in
microglial activation combined with enhanced pro-inflammatory
properties. Microglia were pretreated with a neutralizing antibody
against CX3CR1 for 6 hours, followed by measurement of the
expression of inflammatory cytokines. As a result, the partial
blockade of CX3CR1 function markedly reduced the production
of IL-1b and TNF-a (Fig. 10H–I). In addition, morphometric
analysis showed that the CX3CR1 antibody treated co-cultures
had significantly higher numbers of photoreceptors remaining
than did the untreated ones (data not shown). Also the result of
TUNEL assay indicated that the CX3CR1 antibody treated co-
cultures had lower percentage of TUNEL-positive photoreceptors
than did the untreated ones at 24 hours after exposure. (Fig. 11)
Soluble fractalkine-induced migration of microglia
Chemotaxis assays were performed in the microglia-photore-
ceptor co-cultures. Our data show that microglia exhibited
stronger migratory activity in the cultures with additional
recombinant soluble fractalkine, suggesting that soluble fractalkine
released by photoreceptors after photic injury contributes to the
migratory behavior of microglia in vitro (Fig. 12). When microglia
were pretreated with neutralizing antibody against CX3CR1 for
2 hours, the effect of soluble fractalkine on migration was partly
attenuated (Fig. 12). These findings suggest that the fractalkine/
Figure 8. The changes in microglial morphology in the co-
cultures after exposure to light. (A, C, E, G) Primary retinal microglia
grown in basal media showed ramified shapes with processes. (B, D, F,
H) After exposure to light, the microglia in the co-cultures became
rounder and took on a characteristic amoeboid shape as they were
activated.
doi:10.1371/journal.pone.0035446.g008
Figure 9. The soluble fractalkine release after exposure to
light. ELISA analysis revealed that the levels of soluble fractalkine were
increased in the 661W control group and the 661W+MG co-culture
group. The difference between them is not statistically significant at 6-
hour and 12-hour time points. At other time points, the release of
soluble fractalkine in the 661W control group was less than that of the
co-culture group due to the further degeneration of remaining
photoreceptors caused by activated microglia.
doi:10.1371/journal.pone.0035446.g009
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35446Figure 10. The expression of IL-1b and TNF-a after exposure to light. (A–C) The protein expressions of IL-1b and TNF-a in the retina began to
increase at 6 hours after exposure to light and peaked at 3 days. (D–E) The mRNA expression of IL-1b and TNF-a in the retina was increased, and
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TUNEL assay showed that the soluble fractalkine treated co-
cultures had higher percentage of TUNEL-positive photoreceptors
than did the untreated ones at 24 hours after exposure (Fig. 11).
This might be due to the reason that the increased level of soluble
fractalkine leads to increased recruitment of activated microglia
and excess production of inflammatory cytokines, which will cause
inflammation-mediated neurodegeneration of the remaining
photoreceptors.
Neuroprotective effect of membrane-bound fractalkine
against light-induced toxicity in microglia/photoreceptor
co-cultures
To test whether membrane-bound fractalkine upregulation has
any role in neuroprotection after photic injury, as suggested by
previous studies [49,22], we applied recombinant full-length
fractalkine to the upper chamber. Light-induced cell death was
attenuated in the cultures pretreated with exogenous fractalkine
compared with controls. This protection was further confirmed by
TUNEL assay at 24 hours after exposure (Fig. 13A–F). Statistical
analysis showed that the percentage of TUNEL-positive 661W
cells was significantly lower in the fractalkine treated (51.963.7%)
than in the control group (78.265%, P,0.05) (Fig. 11). Moreover,
the expression of IL-10, one of the anti-inflammatory cytokines
[50], was increased in the full-length fractalkine treated co-
cultures, as measured by ELISA assay (Fig. 13G).
Discussion
In the present study, we sought to determine whether fractalkine
and its sole receptor CX3CR1 were involved in photoreceptor-
microglia cross-talk after blue photic injury, resulting in microglial
activation as well as migration, and subsequently contributing to
the further apoptosis of remaining photoreceptors. First we
confirmed the constitutive expression of fractalkine/CX3CR1 by
photoreceptors and microglia respectively in the retina under
normal and light-damaged conditions. Moreover, the extent of
photoreceptor degeneration and microglial migration paralleled
the increased level of fractalkine/CX3CR1. In addition, we noted
that soluble fractalkine seemed to play a certain role in enhancing
the release of inflammatory cytokines and facilitating microglial
migration. However, recombinant full-length fractalkine might
exert anti-inflammatory effects via IL-10 release and potential
control of microglial activation.
Microglia are the resident immune cells in the CNS that
perform dynamic immune surveillance [51]. In the physiological
state, microglia exist in a resting appearance characterized by
a ramified morphology with protruding processes surveying and
monitoring their microenvironment [52,53]. In response to
pathological stimuli, microglia undergo rapid activation and
quickly migrate to the damaged site to perform the function of
macrophages, including providing innate immunity, phagocytosis,
cellular maintenance, and neurotrophic secretions [54,55].
However, microglia can also promote inflammation and act as
contributors to progressive neuron damage in several neurode-
generative diseases [56]. Substantive evidence indicates that
microglial cells in the retina play an important role in the
development of retinal degenerative diseases [57]. The current
research confirmed that light-induced photoreceptor apoptosis is
often accompanied by microglial activation and migration from
the inner retinal layer to the outer retina and even the subretinal
space, combined with the upregulated expression of pro-in-
flammatory factors including IL-1b and TNF-a [58]. Further-
more, we showed a neuroprotective effect of naloxone against
light-induced photoreceptor degeneration through inhibition of
retinal microglial activation [9]. These observations suggest that
injured photoreceptors must release certain signaling molecules
that attract and activate microglia, resulting in further de-
generation of remaining photoreceptors. Although the interaction
between neurons and microglia are likely critical in regulating
their function and survival, knowledge of the relevant signaling
peaked at 1 day after photic injury as detected by real-time PCR. (F–G) ELISA assay detected the upregulated secretion of IL-1b and TNF-a in the
661W/microglia co-culture supernatant. (H–I) Compared with untreated co-cultures, the group pretreated with neutralizing CX3CR1 antibody showed
significantly decreased expression of IL-1b at 12 hours and 24 hours after exposure to light. For TNF-a, statistical analysis showed significantly
reduced production in the treated cultures at 12 hours. No difference was found between treated and untreated co-cultures at 24 hours.
doi:10.1371/journal.pone.0035446.g010
Figure 11. Statistical analysis of TUNEL assay in different co-
culture groups at 24 hours after exposure to light.
doi:10.1371/journal.pone.0035446.g011
Figure 12. Soluble fractalkine-induced microglial migration in
the co-culture of retinal microglial cells with 661W cells. Results
are presented as numbers of migratory cells. Microglia exhibited
stronger migratory activity in the co-cultures with additional soluble
fractalkine than in other groups and there was a significant reduction of
microglial migration in the co-cultures with neutralizing CX3CR1
antibody at most time points. The most obvious result was obtained
at the 6-hour time point after the beginning of light exposure.
doi:10.1371/journal.pone.0035446.g012
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Fractalkine is a relatively new member of the chemokine family
that is reported to be constitutively expressed by neurons, whereas
its sole receptor, CX3CR1, is mainly expressed by microglia in the
CNS [59]. Different from many other chemokines, fractalkine is
synthesized as a transmembrane protein, which can be cleaved
into a soluble form in certain pathological conditions [60]. This
specific expression pattern implies a role in mediating neuron-
microglia cross-talk. In the present research, we first established
a rat photic injury model to investigate whether there was a change
in fractalkine/CX3CR1 expression in the retina, and whether the
migration of microglia to the injured neurons was associated with
fractalkine/CX3CR1 expression. Western blot and real-time PCR
analysis revealed that the levels of fractalkine/CX3CR1 were
elevated after light exposure, with the increased expression site of
fractalkine exclusively in the photoreceptors. Then, in an in vitro
cell co-culture study, increased soluble fractalkine accumulation
was detected by ELISA assay. This means that part of the
membrane-bound form fractalkine was cleaved and released as
soluble protein. We also noted that the apoptotic peak of
photoreceptors at 1 day was consistent with that of the elevated
level of fractalkine, and both were ahead of the peak of microglial
infiltration at 3 days. Taken together, these findings suggest the
possibility that, after exposure to intense blue light, soluble
fractalkine is initially released by injured photoreceptors, and
thereby causes the migration of microglia into the ONL via
CX3CR1. Moreover, these microglia produce toxic agents which
in turn exacerbate the progressive neurotoxic consequences.
Interestingly, it seems to be organ- and disease-specific for
fractalkine/CX3CR1 to exert either a toxic or a protective effect
[61–62]. On one hand, inactivation of fractalkine or CX3CR1
reduces the severity of some diseases [24,63]. On the other hand,
fractalkine/CX3CR1 signaling represents a potential protective
effect on neurons in many degenerative CNS diseases [22,61]. For
instance, CX3CR1 deficiency dysregulates microglial responses,
resulting in neurotoxicity in models of Parkinson’s disease and
amyotrophic lateral sclerosis [54]. Moreover, adding extra
fractalkine protects hippocampal neurons from glutamate- and
HIV-1-induced neurotoxicity [49,22].
Figure 13. The effect of membrane-bound fractalkine on 661W photoreceptor survival. (A–C) At 24 hours after exposure to light, a large
number of TUNEL-positive photoreceptors was detected in the untreated co-culture. (D–F) TUNEL-positive cells were less abundant in the co-culture
treated with exogenous membrane-bound fractalkine. (G) The expression of anti-inflammatory cytokine, IL-10, was increased in the recombinant full-
length fractalkine treated groups.
doi:10.1371/journal.pone.0035446.g013
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signaling are also controversial. In one study, CX3CR1 deficiency
showed reduced macrophage accumulation but severe neovascu-
larization after alkali injury in the cornea [64]. However, in some
other studies, the same CX3CR1 deficiency conversely led to
microglia accumulation in the ONL and subsequent neuronal
degeneration and neovascularization in an AMD model [65], as
well as in experimental autoimmune uveitis, resulting in
a significant increase in neuron apoptosis and prolonged in-
flammatory response [66]. In this regard, it was our interest to
determine whether fractalkine/CX3CR1 signaling has potential
neurotoxic or neuroprotective effects on light-induced photore-
ceptor degeneration. In the photoreceptor-microglial transwell co-
cultures, we showed that blockade of fractalkine/CX3CR1
interaction by neutralizing antibody against CX3CR1 ameliorated
the microglial inflammatory response to damaged photoreceptors
and improved the photoreceptor survival rate. In addition,
microglial migration was found to be attenuated by this antibody.
Our data also showed a significant increase in microglial migration
and production of TNF-a and IL-1b in vitro in response to
exogenous recombinant soluble fractalkine adding, suggesting that
soluble fractalkine cleavage and distribution in the retina could
affect activation and migration of microglia in vivo. In contrast,
the pretreatment of exogenous full-length fractalkine likely exerted
neuroprotective action on 661W photoreceptors. This effect might
be mediated by promotion of microglial anti-inflammatory
cytokine IL-10 release or by other mechanisms that remain to
be studied.
Taken together, these results strongly suggest that fractalkine/
CX3CR1 signaling exerts multiple effects on the cross-talk
between microglia and photoreceptors. The soluble form of
fractalkine released from photoreceptors may function as a che-
motactic factor to cause the activation and migration of retinal
microglia, while fractalkine in low concentrations in the mem-
brane-bound form may exist as a regulator of the beneficial
balance between microglia and photoreceptors. The reasons for
these differences are not quite clear, but it has been hypothesized
that CX3CR1 activates different signaling pathways in different
situations [65]. However, these intricate effects of fractalkine/
CX3CR1 in the co-cultures reported herein need extensive
investigation in animal models.
In conclusion, changes in the expression of fractalkine/
CX3CR1 in response to intense blue light injury that we have
documented strongly suggest that this ligand–receptor signaling
pathway may play a role in the process of retinal microglial
activation and migration in light-induced photoreceptor degener-
ation. Our results indicate that blockage of soluble fractalkine
represents a decreased inflammatory response, whereas over-
expression of full-length fractalkine suggests a role in photorecep-
tor survival. In this regard, we will further explore potential
downstream intracellular signal transduction pathways in the
future work.
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